Universitatsklinikum Schleswig-Holstein- Campus Kiel

Kiel 24105

2 studies enrolling now · 6 studies all time

What they study most

B-cell Lymphoma, B-cell Malignancy, Chronic Lymphocytic Leukemia, Crohn's Disease, Mantle Cell Lymphoma, Refractory Cancer, Refractory Mantle Cell Lymphoma (MCL), Relapsed Cancer, Relapsed Mantle Cell Lymphoma, Relapsed/Refractory Aggressive B-Cell Lymphoma, Small Lymphocytic Lymphoma, Ulcerative Colitis

Studies at this site

• A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) — Recruiting now
• A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies — Recruiting now
• A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease — Stopped early
• A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell Malignancies — Completed
• Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma — Running, not enrolling
• Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis — Completed